NEXGEL, Inc. (NASDAQ:NXGL) Short Interest Update

NEXGEL, Inc. (NASDAQ:NXGL) was the target of a large decrease in short interest in June. As of June 15th, there was short interest totalling 10,900 shares, a decrease of 16.2% from the May 31st total of 13,000 shares. Currently, 0.2% of the shares of the stock are sold short. Based on an average daily trading volume, of 15,100 shares, the short-interest ratio is currently 0.7 days.

NEXGEL Stock Down 4.2 %

NASDAQ NXGL traded down $0.09 on Tuesday, hitting $2.05. 4,600 shares of the company were exchanged, compared to its average volume of 18,159. The firm has a 50 day moving average of $2.20 and a two-hundred day moving average of $2.31. The company has a quick ratio of 1.41, a current ratio of 1.96 and a debt-to-equity ratio of 0.20. NEXGEL has a 1-year low of $1.46 and a 1-year high of $3.14.

NEXGEL (NASDAQ:NXGL) last released its earnings results on Monday, May 13th. The company reported ($0.14) earnings per share (EPS) for the quarter. NEXGEL had a negative net margin of 67.48% and a negative return on equity of 54.71%. The business had revenue of $1.27 million for the quarter.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in NEXGEL stock. Northeast Financial Group Inc. bought a new stake in shares of NEXGEL, Inc. (NASDAQ:NXGL) during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 11,848 shares of the company’s stock, valued at approximately $32,000. Northeast Financial Group Inc. owned 0.19% of NEXGEL at the end of the most recent quarter. 2.21% of the stock is owned by hedge funds and other institutional investors.

NEXGEL Company Profile

NEXGEL, Inc manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc and changed its name to NEXGEL, Inc in November 2019.